Neural Therapeutics Inc. (CNSX: NURL)
Health Care · Biotechnology · CA
CA$0.02
-25.00% today · 0.0% 1Y
Neural Therapeutics Inc. (CNSX: NURL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.80M.
Over the last twelve months the share price has gained 0.0%, trading between 0.01 and 0.04.
Tweenvest scores Neural Therapeutics Inc. across four factors: quality 25/100, value 53/100. Its strongest factor is value.
NURL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.80M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CA$0.04
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 169.20M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abpro Holdings, Inc.OTCPK: ABPO | $2.08M | $0.35 | -13.90% |
| Anatara Lifesciences LtdASX: ANR | $1.97M | AU$0.01 | -10.00% |
| Transgene Biotek LimitedBSE: 526139 | $1.89M | Rs2.40 | -7.69% |
| Cynata Therapeutics LimitedASX: CYP | $1.86M | AU$0.01 | -8.33% |
| Respiratorius AB (publ)XSAT: RESP | $1.72M | Skr2.06 | -5.07% |
| BioXcel Therapeutics, Inc.OTCPK: BTAI.Q | $1.63M | $0.05 | +35.42% |
| Halberd CorporationOTCPK: HALB | $1.49M | $0.00 | +100.00% |
| Curis, Inc.NasdaqCM: CRIS | $1.48M | $0.71 | -3.69% |
Figures last refreshed Oct 4, 2026.